Home Tags NASDAQ:NBRV

Tag: NASDAQ:NBRV

Nabriva Therapeutics Plc (NASDAQ:NBRV) Announced Q3 2020 Results And Updates On...

Ward Sport - 0

Nabriva’s (NASDAQ:NBRV) XELENTA Shows Efficacy In Treating Community-Acquired Bacterial Pneumonia Patients...

Gavins Felicity - 0

CMS Grants NTAP For Nabriva Therapeutics PLC (NASDAQ:NBRV)’s XENLETA For Injection

Gavins Felicity - 0

Nabriva Therapeutics PLC (NASDAQ:NBRV) Inks A Pact With Amplity Health To...

Matt Wade - 0

The European Commission (EC) Issues a Legal Binding Decision for the...

Gavins Felicity - 0

Nabriva Therapeutics (NASDAQ:NBRV) Soars a Deal with Merck & Co., Inc....

Ward Sport - 0

Nabriva Therapeutics PLC – ADR (NASDAQ:NBRV) Strikes a Marketing and Distribution...

Matt Wade - 0

Nabriva Therapeutics PLC – ADR (NASDAQ:NBRV) Receive The FDA’s Response After...

Matt Wade - 0

EU CHMP Gives Positive Opinion For Nabriva Therapeutics’(NASDAQ:NBRV) XENLETA In Community-Acquired...

Kate Hudson - 0
© BioPharma Journal 2020
.td-post-views{ display: none !important; }